Germline reversion of three amino acid mutations in the heavy chain and six in the light chain of an anti-insulin mAb derived from an insulin-treated T1D patient led to preserved, insulin-specific binding, but with decreased affinity compared to the native, mutated mAb [125]. Here, INS is linked to type 1 diabetes mellitus.